New Zealand, Dec 9 (Canadian-Media): There was no signs of life after the eruption of a volcanic island in New Zealand Monday based on the helicopter survey, media reports said.
"Based on the information we have, we do not believe there are any survivors on the island," police said in a statement.
Police Deputy Commissioner John Tims had previously said out of fewer than 50 people on
the island when it erupted, five were reported dead and the number of missing was in the double digits with no contact with them.
He said both New Zealanders and overseas tourists were among those who were dead, missing or injured. Most of the 18 survivors were injured and some had suffered severe burns, he said.
"When we exited the aircraft, pretty much immediately we could see the plume, almost beginning to envelop the entire island...it was just very rapid in terms of the way it expanded." Tristan Webb, director with a skydiving company in New Zealand, who saw the eruption from above reportedly told the CBC News Network.
A cruise ship that carried some of the tourists who had ventured to the volcano had left from Sydney last week and was scheduled to sail to the capital Wellington on Monday night would instead remain overnight in the Tauranga port until more about the situation is made available.
#AfricanSwineFever; #PigsDeath; #WorldOrganizationforAnimalHealth
Ottawa, Nov 1 (Canadian-Media): Rapidly spreading African swine fever may kill around a quarter of the world's pigs, said the president of the World Organization for Animal Health said Thursday.
Pig at risk of African Swine Fever/Twitter
A world crisis had already arisen due to spread of this fatal disease to countries including China, which has half the world's pigs
The disease's spread in the past year to countries including China, , had inflamed a global crisis, Schipp told reporters at a briefing in Sydney.
"I don't think the species will be lost, but it's the biggest threat to the commercial raising of pigs we've ever seen," said Dr. Mark Schipp, Australia's chief veterinary officer "And it's the biggest threat to any commercial livestock of our generation."
African swine fever, fatal to hogs but no threat to humans, has wiped out pig herds in many Asian countries. Chinese authorities have destroyed about 1.2 million pigs in an effort to contain the disease there since August 2018.
Schipp said quality control was difficult for products such as skins for sausages, salamis and similar foods.
Florida (U.S.A.) October 28, 2019: An announcement was made today by Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global platform biotechnology company, that it has entered into a fully funded collaboration with one of the leading animal health companies, media reports said.
Under the terms of the agreement, Dyadic will apply its proprietary and patented C1 gene expression platform to express three different types of proteins to be evaluated by our collaborator for its potential use in their research and commercial projects.
Dyadic International is developing a potentially significant biopharmaceutical gene expression platform based on the fungus Myceliophthora thermophila, named C1.
Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs (such as virus like particles (VLPs) and antigens), monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins.
"Today's announcement further evidences the broad applications of our C1 technology platform for both human and animal health needs. This collaboration in the animal health markets reinforces our momentum in another high growth sector, companion and farm animal health. The regulatory pathway in animal health, compared to human trials for biologics approvals, is much shorter with the cost of goods being a much more critical issue. We believe that our C1 technology platform uniquely addresses these issues and provides us with another potential catalyst for growth," said CEO Mark Emalfarb.
"We are excited to announce an additional animal health-related research agreement...to help speed the development, lower the cost and improve the performance of biologic vaccines and drugs for both farm and companion animals...increasing interest from both our previously announced collaborators as well as other bio-pharmaceutical companies involved in the animal health sector," commented Matthew Jones, Dyadic's Chief Commercial Officer.